Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Inception Fertility Celebrates Tennessee's IVF Protection Bill
-
TV STARS WALK THE WALK FROM COAST TO COAST AT PANCAN PURPLESTRIDE, THE ULTIMATE WALK TO END PANCREATIC CANCER
-
COPT Defense Reports First Quarter 2025 Results
-
Affinia Therapeutics to Present New Data on its AFTX-201 Program in BAG3 Dilated Cardiomyopathy, BBB-Penetrant AAV Capsids, and Proprietary Manufacturing Technology at the 28th Annual American Society
-
EarthLabs Reports Results For The Fourth Quarter and Fiscal Year 2024
-
Blade Air Mobility Announces Date for First Quarter Ending March 31, 2025 Earnings Release Conference Call
-
Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
-
MRVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - MRVI
-
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
-
RBB Bancorp Reports First Quarter 2025 Earnings
-
Trident Filed 2024 Annual Report on Form 20-F
-
WhiteHorse Finance, Inc. To Report First Quarter 2025 Financial Results
-
Orange County Fire Authority in California Selects MSA Safety's G1 Breathing Apparatus to Help Protect Firefighters
-
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
-
Perimeter Medical Imaging AI to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
-
Nucor Reports Results for the First Quarter of 2025
-
REMAX Names Daniel Dennis SVP of Sales and Service, Reinforcing Commitment to Broker and Agent Success
-
Steel Dynamics Announces Second Quarter 2025 Cash Dividend
-
LINKBANCORP, Inc. Announces Record First Quarter 2025 Earnings and Declares Dividend
-
Alerus Financial Corporation Reports First Quarter 2025 Net Income of $13.3 Million
-
Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow
-
SunCar Technology Reports 2024 Annual Results
-
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
-
Encompass Health to participate in BofA Securities 2025 Healthcare Conference
-
German American Bancorp, Inc. (GABC) Reports First Quarter 2025 Earnings; Closes on Heartland Merger
-
Obsidian Therapeutics to Present Preclinical Data Supporting Novel Application of cytoDRiVE® Platform at the American Society of Gene and Cell Therapy Annual Meeting
-
United Security Bancshares Appoints Jay Gill as Vice Chairman
-
Nordson Corporation Announces Medical and Fluid Solutions Segment Leadership Transition
-
Encoded Therapeutics to Present New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
-
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
-
Edgewater Wireless Joins CHIPS North Executive Summit to Share Advances in Wi-Fi Spectrum Slicing
-
NaaS Technology Inc. Announces Completion of ADS Ratio Change
-
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
-
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
-
Bakkt Schedules Conference Call to Discuss First Quarter 2025 Results
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Lincoln Electric to Present at the Oppenheimer 20th Annual Industrial Growth Conference
-
Customers Bancorp, Inc. Declares Quarterly Cash Dividend on Its Series E and Series F Preferred Stock
-
Triton International Declares Quarterly Dividends on Preference Shares
-
Archer To Report First Quarter 2025 Operating Update and Financial Results on May 12, 2025
-
iHeartMedia, Inc. to Report Quarterly Financial Results on May 12, 2025
-
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
-
SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024
-
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
-
Phoenix Asia Holdings Limited Announces Closing of Its Initial Public Offering
-
Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
-
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
-
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer
-
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
-
iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

